Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)

HKG:9989 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	2,001	1,422	1,766	2,139	2,944	2,712
Short-Term Investments	-	387.17	206.2	-	-	74.21
Trading Asset Securities	1,101	867.9	414.18	1,312	981.16	828.21
Cash & Short-Term Investments	3,102	2,677	2,386	3,450	3,925	3,615
Cash Growth	23.84%	12.19%	-30.85%	-12.10%	8.59%	159.98%
Accounts Receivable	1,390	1,187	1,275	1,626	1,543	1,694
Other Receivables	92	173.3	121.89	134.82	243.81	184.16
Receivables	1,482	1,360	1,396	1,761	1,787	1,878
Inventory	4,953	5,394	6,654	6,844	4,708	3,168
Prepaid Expenses	-	123.18	111.28	-	-	-
Other Current Assets	337.08	67.15	56.43	334.53	349.43	467.34
Total Current Assets	9,874	9,621	10,604	12,390	10,770	9,129
Property, Plant & Equipment	2,623	2,854	2,849	2,477	2,537	2,571
Long-Term Investments	1,817	1,823	2,514	2,464	2,618	3,999
Goodwill	2,354	2,357	2,322	2,351	2,152	2,203
Other Intangible Assets	386.64	301.57	370.78	522.87	546.87	615.95
Long-Term Deferred Tax Assets	283.62	282.51	320.5	141.48	121.72	83.94
Long-Term Deferred Charges	5.19	5.1	18.64	244.71	241.88	230.33
Other Long-Term Assets	202.99	98.61	203.87	224.95	120.85	194.36
Total Assets	17,546	17,344	19,203	20,816	19,108	19,026
Accounts Payable	316.2	299.69	306.34	427.43	385.79	239.22
Accrued Expenses	94.66	393.1	388	377.51	398.43	395.33
Short-Term Debt	1,820	844	1,069	2,385	1,886	1,860
Current Portion of Long-Term Debt	744.42	1,523	2,556	1,635	1,382	622.21
Current Portion of Leases	-	38.82	37.8	35.69	31.75	25.6
Current Income Taxes Payable	213.49	120.26	157.18	112.3	113.2	43.74
Current Unearned Revenue	253.28	264.28	362.05	433.88	383.79	265.04
Other Current Liabilities	432.39	215.92	110.24	168.2	210.34	161.93
Total Current Liabilities	3,874	3,699	4,986	5,576	4,791	3,613
Long-Term Debt	979.89	1,081	1,810	2,297	2,250	3,086
Long-Term Leases	49.37	57.77	90.42	110.75	104	51.64
Long-Term Unearned Revenue	45.28	27.29	30.43	32.55	16.67	18.74
Long-Term Deferred Tax Liabilities	223.99	242.49	252.57	328.92	275.36	427.67
Other Long-Term Liabilities	33.26	10.35	10.15	29.39	26.44	24.76
Total Liabilities	5,206	5,141	7,215	8,407	7,585	7,337
Common Stock	1,467	1,467	1,467	1,467	1,467	1,467
Additional Paid-In Capital	-	7,529	7,529	5,859	5,944	6,035
Retained Earnings	4,735	4,588	3,941	4,861	4,184	4,212
Comprehensive Income & Other	6,085	-1,436	-1,024	125.52	-183.36	-145.09
Total Common Equity	12,287	12,149	11,913	12,313	11,411	11,569
Minority Interest	53.02	53.45	75.23	96.72	111.96	119.6
Shareholders' Equity	12,340	12,202	11,988	12,409	11,523	11,689
Total Liabilities & Equity	17,546	17,344	19,203	20,816	19,108	19,026
Total Debt	3,593	3,545	5,563	6,464	5,654	5,645
Net Cash (Debt)	-491.31	-867.91	-3,177	-3,013	-1,729	-2,030
Net Cash Per Share	-0.33	-0.59	-2.15	-2.05	-1.18	-1.50
Filing Date Shares Outstanding	1,467	1,467	1,467	1,467	1,467	1,467
Total Common Shares Outstanding	1,467	1,467	1,467	1,467	1,467	1,467
Working Capital	6,000	5,922	5,618	6,814	5,978	5,516
Book Value Per Share	8.37	8.28	8.12	8.39	7.78	7.88
Tangible Book Value	9,547	9,490	9,220	9,439	8,712	8,751
Tangible Book Value Per Share	6.51	6.47	6.28	6.43	5.94	5.96
Land	-	34.51	34	33.43	30.61	31.32
Buildings	-	1,931	1,915	1,480	1,450	1,445
Machinery	-	2,007	1,961	1,892	1,719	1,693
Construction In Progress	-	697.77	468.72	394.53	425.35	364.39
Leasehold Improvements	-	15.73	15.43	-	-	-

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.